Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on resource Utilization and Costs Associated with Cardiogenic Shock Complicating Myocardial Infarction in a Population-Based Cohort Study

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on characteristics and Outcomes of Adults with Congenital Heart Disease in the Cardiac Intensive Care Unit

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on STEMI, revascularization, and peak troponin by adverse pregnancy outcomes in women with myocardial infarction

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on the association of Gestational Diabetes with Subclinical Cardiovascular Disease

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on PARCCS, a Machine Learning Risk-Prediction Model for Acute Peripartum Cardiovascular Complications during Delivery Admissions

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on Cardiovascular Disease in Pregnancy, including Clinical Outcomes and Cost-Associated Burdens from a National Cohort at Delivery

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on an experience Curve with the Cone Procedure for Ebstein's Anomaly showing Effect on Cost and Resource Utilization

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on clinical and 2/3D-echo determinants of mitral valve reoperation in children with congenital mitral valve disease

Jennifer Kwan, MD PhD, and Andrew Nguyen, MD discuss clonal hematopoiesis and the associated risk of cardiotoxicity during solid tumor treatment.

Gregory Hundley, MD, and Christina Dieli-Conwright, PhD, MPH discuss the importance of physical activity and cardio-oncology rehabilitation to reduce cardiovascular risk in patients with cancer. Moderated by Nicholas Wilcox, MD, MHS.

Alexander Lyon, MD PhD and Sivatharshini Ramalingam, MD discuss the evolution of Dr Lyon's career in cardio-oncology, the current landscape of cardiotoxicity and essential tips for future leaders

Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Luke Dawson, MBBS, MPH, discuss a recently published original research paper that aimed to assess the interactive effects of coronary complexity on PCI and CABG outcomes and identify the optimal threshold where PCI can be considered a reasonable option.

Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Jun Jiang, MD, discuss a recently published original research paper on a study that aimed to evaluate the prognostic impact of coronary microvascular function in patients with NSTEMI, as determined by angio-IMR.

Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Firas Zahr, MD, discuss a recently published original research paper on a study that aimed to assess the impact of tricuspid regurgitation on outcomes of TAVR with balloon expandable valves.

Pratik Doshi, MD, MS, and Daniel Forman MD, FACC, explore the challenges of geriatric cardiology and the critical importance of distinguishing between chronological and biological age in treating older adults. They highlight how geroscience is revolutionizing heart care, with in-depth discussions on topics like inflammation, frailty, and polypharmacy. The episode offers practical tips and insights that can transform approaches to cardiovascular care for aging populations.

Mirza Umair Khalid, MD, social media editor of JACC: Cardiovascular Interventions, and Toshiki Kuno, MD, PhD, discuss a recently published original research paper examining the comparison of outcomes between leadless (micra) and transvenous pacemakers after TAVR.

Mirza Umair Khalid, MD, social media editor of JACC: Cardiovascular Interventions, and Devraj Sukul, MD, MSc, discuss a recently published original research paper assessing the contemporary trends and outcomes of IVL versus atherectomy (rotational & orbital) in PCI.

Audio Summary of the August Issue with Introduction by Dr. Bonnie Ky

In this podcast, Dr. Fleure Gallant and Dr. Reshma Jagsi discuss a pivotal study by Busschaert et al. on the cost-effectiveness of Deep Inspiration Breath Hold (DIBH) in left-sided breast cancer radiotherapy. They highlight how DIBH significantly reduces heart radiation dose and cardiac events, while also noting its higher costs and impact on clinical workflow, ultimately concluding that DIBH remains a cost-effective option compared to free breathing techniques.

In this podcast, Katelyn Atkins discusses a study led by Dr. Gerard Walls from Queens University, Belfast, which investigates cardiac volumetric parameters from radiation planning CTs to predict major adverse cardiac events in patients with non-small cell lung cancer. The research highlights how baseline cardiac volumes, especially the left atrium and the left-to-right ventricle ratio, correlate with specific cardiac risks, emphasizing the need for optimized cardiovascular risk management and further exploration of these imaging markers.

In this podcast, Gerard Walls reviews a pivotal study led by Dr. Katelyn Atkins on radiation-induced arrhythmias in patients with locally advanced non-small cell lung cancer. The research provides a groundbreaking analysis of how radiation doses impact various types of arrhythmias, offering new insights for predicting and mitigating these common cardiac side effects.

In this podcast, Dr. Tim Markmann discusses a groundbreaking method for treating cardiac tumors using echocardiography-guided transapical radiofrequency ablation. This innovative approach from Dr. Liwen Liu and his team, which involves delivering thermal energy to the tumor via a percutaneous needle, shows promising results in reducing tumor size and alleviating heart failure symptoms, though it requires further study to address potential risks such as ventricular arrhythmias.

In this podcast, Dr. Katrina Poppe reviews a study by Celeste McCracken and Dr. Zahra Raisi-Estabragh that evaluates the effectiveness of cardiovascular risk scores in cancer survivors using UK Biobank data. The research reveals that standard risk scores often underestimate cardiovascular risk in cancer survivors, particularly those with Hodgkin's lymphoma, hematological cancers, and brain malignancies, highlighting the need for tailored risk assessment tools for this population.

In this podcast, Dr. Nowell Fine discusses a study on atrial fibrillation as a prognostic factor in patients with transthyretin amyloidosis cardiomyopathy, highlighting its high prevalence but limited prognostic significance. The research, part of the TTR ACT trial, underscores the need for ongoing investigation into optimal management strategies for atrial fibrillation in this complex patient population.

Mohamed Al Kazaz, MD, shares insights into valvular disease in Asia, epidemiology of rheumatic heart disease, and lifelong management strategies. Moderated by Neeja Patel, MD.